Skip to main content


Erratum to: Therapeutic assessment of chloroquine–primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India

Article metrics

The original article was published in Malaria Journal 2015 14:310

Erratum to: Malar J (2015) 14:310 DOI 10.1186/s12936-015-0824-y

The authors of the original article [1] have recently noticed that the published paper contained some errors.

In Table 2, ‘Life table showing estimates of risk of therapeutic failure during 28 days follow-up in cohort of P. vivax monoinfection patients from southwestern India treated with chloroquine (25 mg/kg over 3 days) followed by primaquine (0.25 mg/kg daily for 14 days)’, the column “IR (interval risk)” should have read “CSP (cumulative survival probability)”. Table 2 is correctly displayed in this erratum.

Table 2 Life table showing estimates of risk of therapeutic failure during 28 days follow-up in cohort of P. vivax monoinfection patients from southwestern India treated with chloroquine (25 mg/kg over 3 days) followed by primaquine (0.25 mg/kg daily for 14 days)

Further, in the first paragraph of the ‘Discussion’ section, another case report should have been mentioned in the final sentence, to read as follows: “Nonetheless, of the published literature from India, only two case reports dating back over two decades confirms CQ failure in P. vivax despite having adequate plasma concentration of CQ [17,18].”

A new Reference 18 [2] should have been included and the subsequent references renumbered to 19–26.


  1. 1.

    Rishikesh, et al. Malar J. 2015;14:310. doi:10.1186/s12936-015-0824-y.

  2. 2.

    Garg M, Gopinathan N, Bodhe P, Kshirsagar NA. Vivax malaria resistant to chloroquine: case reports from Bombay. Trans R Soc Trop Med Hyg. 1995;89:656–7.

Download references

Author information

Correspondence to Kavitha Saravu.

Additional information

The online version of the original article can be found under doi:10.1186/s12936-015-0824-y.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.